TokenPost·
Taysha Gene Therapies Posts Third-Quarter 2026 Loss of $0.10 Per Share
The net loss per common share was the same on a basic and diluted basis.
More news
- TokenPostKraft Heinz Sets 2027 Outlook, Expects Growth to Return in Second Half
- TokenPostJD.com Takes Control of CECONOMY in €1.335 Billion Deal
- TokenPostCorteva Sales Fall 9% as Latin America Organic Sales Drop 31%
- Crypto BriefingHouthis claim attack on Saudi oil facility in Yanbu
- Crypto BriefingAnthropic CEO predicts AI will eliminate major diseases within a decade
- TokenPostLatch Posts $14.1 Million in Third-Quarter Revenue, $0.13 Loss Per Share